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ABSTRACT
Background: Chronic obstructive pulmonary disease (COPD)
is a common cause of morbidity and mortality affecting a
large number of individuals in both developed and developing
countries and it represents a significant financial burden for
patients, families and society. Pulmonary rehabilitation (PR)
is a multidisciplinary program that integrates components of
exercise training, education, nutritional support, psychologi-
cal support and self-care, resulting in an improvement in dys-
pnea, fatigue and quality of life. Despite its proven effective-
ness and the strong scientific recommendations for its rou-
tine use in the care of COPD, PR is generally underutilized and
strategies for increasing access to PR are needed. Home-
based self-monitored pulmonary rehabilitation is an alterna-
tive to outpatient rehabilitation. In the present study,
patients with mild, moderate and severe COPD submitted to
either an outpatient or at-home PR program for 12 weeks
were analyzed. 
Methods: Patients who fulfilled the inclusion criteria were
randomized into three distinct groups: an outpatient group
who performed all activities at the clinic, a home-based group
who performed the activities at home and a control group. PR
consisted of a combination of aerobic exercises and strength-
ening of upper and lower limbs 3 times a week for 12 weeks.
Results: There was a significant difference in the distance cov-
ered on the six-minute walk test (p < 0.05) and BODE index (p
< 0.001) in the outpatient and at-home groups after partici-
pating in the rehabilitation program compared to baseline. 
Conclusion: A home-based self-monitoring pulmonary reha-
bilitation program is as effective as outpatient pulmonary
rehabilitation and is a valid alternative for the management
of patients with COPD.
Keywords: COPD, home-based pulmonary rehabilitation, pul-
monary rehabilitation.
RIASSUNTO 
Razionale: La broncopneumopatia cronica ostruttiva (BPCO) è
una causa frequente di morbilità e mortalità che colpisce
un’ampia quota di popolazione sia nel mondo industrializzato
che nei Paesi in via di sviluppo e rappresenta un peso econo-
mico di rilievo per pazienti, familiari e collettività. La riabilita-
zione respiratoria (PR) è un programma multidisciplinare che
inegra componenti di riallenamento all’esercizio fisico, educa-
zionale, supporto nutrizionale, supporto psicologico ed auto-
aiuto, che porta ad un miglioramento della dispnea, della af-
faticabilità e della qualità della vita. Nonostante la provata
efficacia e le forti raccomandazioni delle società scientifiche
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al suo impiego routinario nel trattamento della BPCO, la PR è
generalmente sottoutilizzata e si rendono perciò necessarie
strategie per aumentarne l’utilizzo. La PR effettuata a domici-
lio ed auto-monitorata dal paziente stesso è un’alternativa
alla classica riabilitazione ambulatoriale. In questo studio so-
no stati valuati pazienti con BPCO di grado lieve, moderato e
grave sottoposti a un programma di PR ambulatoriale o domi-
ciliare.
Metodi: I pazienti eligibili allo studio sono stati randomizzati
in tre gruppi: un gruppo ambulatoriale che effettuava tutte le
attività in ospedale, un gruppo domiciliare che effettuava il
programma a domicilio ed un gruppo di controllo. Il program-
ma di PR consisteva in una combinazione di esercizi aerobici e
di rafforzamento della muscolatura degli arti superiori e infe-
riori per 3 volte la settimana per 12 settimane.
Risultati: Sia nel gruppo che ha partecipato al PR ambulatoria-
le che in quello domiciliare si sono rilevate differenze signifi-
cative rispetto alle misure di base nella distanza coperta con
il test del cammino di 6 minuti (p < 0.05) che nell’indice BODE
(p < 0.001). 
Conclusioni: Un programma di riabilitazione respiratoria auto-
monitorato eseguito a domicilio ha efficacia sovrapponibile ad
un programma ambulatoriale e può perciò essere considerato
una valida alternativa nella gestione del paziente con BPCO.
Parole chiave: BPCO, riabilitazione respiratoria domiciliare,
riabilitazione respiratoria.  
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a
common cause of illness and death that affects a
large and increasing number of individuals in both
developed and developing countries. Estimates sug-
gest that COPD will become the 3rd most common
cause of death in the world and 5th most common
cause of illness in the next 20 years [1,2].
Pulmonary rehabilitation (PR) is a multidisciplinary
intervention that integrates physical exercise, nutri-
tional therapy, patient education and psychological
support [3-7]. Evidence indicates that PR offers
numerous clinical benefits, such as improved
health-related quality of life, a reduction in anxiety
and depression, increased tolerance to physical
exercise and a reduction in the number of hospital-
izations and days of hospital stay per year [3,4].
However, despite the strong scientific recommen-
dations for its routine use in the treatment of COPD,
PR is generally underutilized [5-7]. A survey carried
out in 2005 in Canada demonstrated that only 1-2%
of the Canadian population with COPD has access
to rehabilitation programs [8]. Similar statistics are
reported for other countries [7,9].
A search of the scientific literature revealed few
controlled studies that demonstrate the benefits of
self-monitored pulmonary rehabilitation programs
for patients with COPD. The majority of these stud-
ies demonstrate the effectiveness of home-based
PR, with similar results to those obtained in a clini-
cal setting involving the direct supervision of 
physiotherapists [8-11]. The aim of the present study
was to carry out a comparative analysis of patients




A randomized controlled prospective study with a
consecutive sample was carried out. The study
received approval from the Ethics Committee of the
Nove de Julho University (Brazil) under protocol
number 306654/2008. All participants gave their
informed consent agreeing to participate in the study
and were permitted to abandon the study at any time
with no negative consequences. 
The initial sample was made up of 216 patients who
sought treatment at a private pulmonology clinic in
the city of Cascavel (southern Brazil). The patients
were randomized electronically by a computer into
three groups as follows: outpatient rehabilitation, at-
home rehabilitation and a control group. The primary
outcome was the difference in distance walked on
the six-minute walk test (6MWT). The secondary out-
come was the variation in the BODE index.
Patients 
The following were the inclusion criteria: COPD
based on the GOLD classification [1]; clinical sta-
bility in the eight weeks prior to the study (no
reports of worsening of dyspnea, increased phlegm
production or phlegm purulence). The exclusion
criteria were: hospitalization; COPD instability;
presence of neuromuscular disease, associated res-
piratory disease, orthopedic or neurological disease
that affected gait; recent impairment due to comor-
bidities, such as myocardial infarction, heart failure,
stroke or neoplasm; prior pneumonectomy or other
thoracic surgery. The presence of stable comorbidi-
ties was not considered an exclusion criterion as
most patients with COPD are elderly and common-
ly affected by multiple comorbidities [12]. All
patients who sought care at the clinic and fulfilled
these criteria were considered eligible for the study.
Measurements
All patients underwent a physical and spirometric
evaluation [13], determination of weight and height
for the calculation of the body mass index (BMI),
assessment with the modified Medical Research
Council (MMRC) scale [14] and the 6MWT, based
on the recommendations of the American Thoracic
Society [15]. The BODE index was determined at
this time using the variables identified in this base-
line evaluation, as previously described [16]. The
BODE index is a multidimensional 10-point scale
based on four variables: FEV1 (as percent predicted),
distance walked in 6 minutes (expressed in meters),
MMRC dyspnea scale, and the body-mass index, in
which higher scores indicate a higher risk of death
(see Table I). Two duly trained health care profes-
sionals were responsible for the evaluations, which
were performed by the same evaluators for all
patients. 
The outpatient group performed all the PR activities
in the clinic under the supervision of a physiothera-
pist. The at-home group performed the same PR





























did not perform any PR activities and was merely
accompanied clinically. The PR program lasted 12
weeks, after which the individuals were evaluated a
second time. At the end of the study, all participants
were encouraged to continue the PR activities at
home. Telephone contact was made each month by
a blind evaluator, who inquired about the general
health status of the individuals, adverse effects and
the continuity of the physical activities. Figure 1 dis-
plays the flowchart of the study. All patients (in the
three groups) were treated with bronchodilators
associated to inhaled corticoids when needed, in
accordance with the GOLD guidelines [1].
Interventions
Educational program
During the initial evaluations, all patients took part
in an educational program in the auditorium at the
clinic, where they received information on the
development and progression of COPD, its treat-
ment (both pharmacological and non-pharmaco-
logical), the correct use of oxygen for oxygen-
dependent patients and the importance of an exer-
cise-based rehabilitation program. All patients
received a chart containing the content of the edu-
cational program.
Outpatient pulmonary rehabilitation program
The outpatient group performed a combination of
aerobic and strengthening exercises three mornings
a week for three months. Each session was made up
of active warm-up exercises, strengthening of upper
and lower limbs, aerobic exercises and stretching.
The warm-up phase consisted of intercalated callis-
thenic exercises for different muscle groups, based
on the tolerance of each patient. 
The upper limb exercises were performed with
hand weights while seated comfortably and consist-
ed of 10 repetitions of elbow flexion, 10 repetitions
of elbow abduction, 10 repetitions of shoulder
abduction and 10 repetitions of shoulder flexion.
The lower limb exercises were performed with
ankle weights while patients were seated comfort-
ably and consisted of 10 repetitions of hip flexion
and 10 repetitions of knee extension. These exercis-
es were performed to the maximal range of motion
of each patient, with diaphragm and pursed-lips
breathing. The initial load was 50% of the maximal
load achieved on the maximal repetition test (1MR)
for the upper and lower limbs [4], with an increase
of 0.5 Kg every two weeks until reaching the toler-
ance limit of each patient. The test for the determi-
nation of 1MR consisted of a brief five-minute warm
up with upper limb exercises (Kabat diagonals and
shoulder flexion-extension), followed by a progres-
sive increase in load until reaching the greatest load
moved throughout the total joint range [17].
Aerobic exercise consisted of walking on a tread-
Assessed for eligibility (n = 216)
Entered rehabilitation program (n = 117)
Control (n = 29)At home rehabilitation
(n = 42)
12-week evaluation (n = 33) 12-week evaluation (n = 29)
Abandoned program (n = 7)
 Lost to follow up (n = 2)
Abandoned program (n = 19)
 Lost to follow up (n = 4)
Outpatient rehabilitation
(n = 46)
Did not fulfill eligibility criteria (n = 32)
Refused to participate (n = 65)
Died (n = 2)
12-week evaluation (n = 23)































mill for 30 minutes at an intensity of 60 to 80% of
maximal heart rate reached on the 6MWT, which
was monitored throughout the training. Patients
with oxyhemoglobin desaturation (SpO2 ≤ 88%)
induced by the initial 6MWT session and those who
were already oxygen dependent used oxygen sup-
plementation in order to maintain SpO2 ≥ 92%. In
cases of severe dyspnea or complications (dizzi-
ness, unusual discomfort in the precordial region or
lower limbs), the exercise was immediately inter-
rupted and the patient was evaluated by a pneumol-
ogist.
Home pulmonary rehabilitation program
The at-home group performed the same combina-
tion of upper and lower-limb strengthening exercis-
es as the outpatient group for the same amount of
time. In cases in which the patient was unable to
afford the hand and ankle weights, weights were
provided by the clinic for the same function. The
patients in this group initially received training from
a specialized health care professional at the pneu-
mology clinic and were instructed to follow the pro-
posed protocol at home. Aerobic exercise was per-
formed by means of walks on flat ground at 60 to
80% of the maximal heart rate reached on the
6MWT performed at the clinic. A heart monitor
(Polar S810, Polar®, Finland) provided by the clinic
to all patients was used to monitor heart rate. A log
was designed and the patients were instructed to fill
it out at the end of each training session.
During the 12-week period, the individuals
received telephone calls from the same professional
at the clinic in order to follow up on the load
increase, detect problems, clarify questions and
reinforce the importance of the rehabilitation. The
patients were instructed, in the case of a high
degree of dyspnea or any other symptoms of respi-
ratory distress, to reduce the intensity of exercise or
cease the exercise and contact the pneumologist.
The criteria for at-home oxygen therapy and the
protocol for increasing the load on the upper and
lower limb exercises were the same as those for the
outpatient group. 
Statistical analysis 
The sample size was calculated based on the study
by Shahin et al. [18], in which the standard devia-
tion on the post-home rehabilitation 6MWT was 19
meters. Considering a clinically significant differ-
ence of 54 meters [19], α = 5% and 90% power, it
was determined that a minimum of 23 patients was
needed for each group. The Kolmogorov-Smirnov
test was used to test the normality of the distribution
of the variables studied. For the intra-group compar-
isons, Student’s paired t-test was used for variables
with parametric distribution; the Mann-Whitney
test was used for variables with non-parametric dis-
tribution. Inter-group comparisons were performed
using one-way analysis of variance (ANOVA) and
Tukey’s post test was used for paired comparisons
whenever ANOVA rejected the null hypothesis. The
Kruskal-Wallis test was used for inter-group com-
parisons of variables with non-parametric distribu-
tion and the Mann-Whitney test was used for paired
comparisons when the null hypothesis was reject-
ed. The chi-square test was used to test associations
between groups and intensity of symptoms/hospi-
talization. All analyses were carried out using the
Statistical Package for the Social Sciences, version
13.0 for Windows (SPSS, Chicago, IL, USA), with
the level of significance set at 5%.
RESULTS
Between January 2007 and May 2009, 216 consec-
utive patients who sought treatment at the Institute
of the Lung, Cascavel, PR, Brazil were evaluated
and 117 were considered eligible for the study
(Figure 1). These patients were divided into three
groups: 42 in the at-home group, 46 in the outpa-
tient group and 29 in the control group. After the
study had begun, seven patients in the at-home
group and 19 in the outpatient group abandoned
the study. Moreover, follow up losses occurred with
two patients in the at-home group and four in the
outpatient group. 
Patient characteristics 
Table II shows the demographic and anthropomet-
ric data of the study population. Mean age was 69.2
± 8.7 years. Mean weight was 67.8 ± 17.4 Kg.
Males accounted for 76.5% of the sample. The
main cause related to the development of COPD
was past or present smoking habits (94.1% of
cases); three such cases were likely due to second-
TABLE I: PARAMETERS AND SCORING SYSTEM OF THE BODY-
MASS, AIRFLOW OBSTRUCTION, DYSPNEA AND EXERCISE
CAPACITY (BODE) INDEX*    
Variable Points on BODE Index
0 1 2 3
FEV1 ≥ 65 50–64 36–49 ≤ 35
(% of predicted)†
Distance walked ≥ 350 250–349 150–249 ≤ 149
in 6 min (m)   
MMRC dyspnea 0–1 2 3 4
scale‡
Body-mass index§ > 21 ≤ 21
* Cutoff values for the assignment of points are shown for each
variable.
Total possible BODE score ranges from 0 to 10. 
† Forced expiratory volume in 1 second (FEV1) categories are based
on stages identified by the American Thoracic Society.
‡ Scores on the modified Medical Research Council (MMRC) dyspnea
scale can range from 0 to 4, with a score of 4 indicating that the
patient is too breathless to leave the house or becomes breathless
when dressing or undressing.
§ The values for body-mass index were 0 or 1 because of the inflect -
ion point in the inverse relation between survival and body-mass
index at a value of 21. 





























hand smoke. Mean tobacco smoke exposure was
43.6 ± 34.4 pack years. Another, less frequent cause
was exposure to biomass (wood-burning stove and
crop burning), which occurred in three patients
(3.5%). Mean BMI was 24.5 ± 5.7 kg/m2; 66
patients (77.6%) had a BMI > 21 kg/m2.
Table III shows the clinical characteristics of the
patient population. Cough was the most common
symptom (90.5%), followed by dyspnea (74.1%),
wheezing (71.8%) and bronchial secretion (36.5%).
Mean post-bronchodilator forced expiratory vol-
ume in one second (FEV1) in % of predicted value
was 46.5 ± 22.0%, with the majority of patients in
more advanced stages (GOLD III and IV respective-
ly 34.1% and 28.2%). At the beginning of the study,
40 patients (47.0% of the sample) were on long-
term home oxygen therapy.
In the intra-group comparisons, the variation in the
distance walked on the 6MWT at the end of the 12-
week period was clinically significant in the outpa-
tient group (93.6 ± 70.6 meters, p < 0.05) and at-
home group (73.2 ± 50.2 meters, p < 0.05) in rela-
tion to the initial results (Figure 2). 
There was no significant difference in the improve-
ment on the 6MWT between the outpatient and at-
home groups (p = 0.44). The control group demon-
strated no change on the 6MWT at the end of the
study (Figure 3).
TABLE II: PATIENT CHARACTERISTICS OF THE THREE STUDY GROUPS    
Characteristics At-home Outpatient Control
n = 33 n = 23 n = 29
Age (years) 66.4 ± 9.5 71.3 ± 6.7 70.8 ± 8.7
Gender (male/female) 27/6 19/4 19/10
Weight (Kg) 70.0 ± 18.7 66.1 ± 13.0 66.7 ± 19.1
Height (cm) 166.9 ± 9.2 167.0 ± 8.5 162.9 ± 10.7
BMI (kg/m2) 25.0 ± 6.2 23.5 ± 4.2 24.6 ± 6.3
Smoker (ex and current) 32 (97%) 20 (86.9%) 28 (96.5%)
Pack years 61.0 ± 41.9 24.0 ± 16.6 32.7 ± 19.4
Data expressed as mean ± standard deviation or percentage (in parentheses).
Definition of abbreviation: BMI, body mass index. 
TABLE III: CLINICAL CHARACTERISTICS AT BASELINE EVALUATION OF THE THREE STUDY GROUPS    
Variables At-home Outpatient Control
n = 33 n = 23 n = 29
Dyspnea – MRC 0 8 (24.2) 6 (26.1) 8 (27.6)
Dyspnea – MRC 1 9 (27.3) 8 (34.8) 8 (27.6)
Dyspnea – MRC 2 10 (30.3) 5 (21.7) 10 (34.5)
Dyspnea – MRC 3 6 (18.2) 4 (17.4) 2 (6.9)
Dyspnea – MRC 4 0 (0) 0 (0) 1 (3.4)
Cough 31 (93.9) 20 (86.9) 26 (89.6)
Secretion 12 (36.4) 8 (34.8) 11 (37.9)
Wheezing 26 (78.8) 15 (65.2) 20 (69.0)
Post-bronchodilator spirometry
FVC (L) 2.19 ± 0.71 2.51 ± 0.82 2.22 ± 0.55
FVC (%) 68.7 ± 30.2 79.1 ± 30.0 69.9 ± 28.0
FEV1 (L) 1.31 ± 0.76 1.32 ± 0.68 0.99 ± 0.46
FEV1 (%) 47.5 ± 23.3 51.5 ± 23.9 41.4 ± 18.4
FEV1/FVC (%) 69.1 ± 21.8 65.1 ± 24.5 59.2 ± 20.6
COPD stage
GOLD I 4 (12.1) 2 (8.7) 2 (6.9)
GOLD II 8 (24.2) 10 (43.5) 6 (20.7)
GOLD III 11 (33.3) 5 (21.7) 13 (44.8)
GOLD IV 10 (30.3) 6 (26.1) 8 (27.6)
BODE 4 (0-7) 4 (0-8) 4 (1-9)
Data expressed as absolute number and percentage (in parentheses) or mean ± standard deviation.
Definition of abbreviatons: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; FVC, forced vital capa-































There was a significant reduction in the BODE
index in the outpatient and at-home groups at the
end of the 12-week period (p < 0.001) and the
patients in the control group also demonstrated a
significant improvement (p = 0.01) (Figure 4). In the
inter-group comparisons, there was no significant
difference in the variation in BODE index between
the outpatient and at-home groups (p = 0.90),
whereas both these groups achieved a significantly
greater reduction in the index in comparison to the
control group (p = 0.010 and p = 0.016, respectively). 
DISCUSSION 
PR focuses on the multiple needs of patients with
COPD and is one of the approaches to reducing
disability stemming from this progressive, chronic
disease [4,20]. However, there is limited availability
of PR programs in most countries and few patients
are submitted to this treatment modality [7-9].
Moreover, PR carried out in a clinical setting and
based on hospital guidelines requires qualified
health care professionals, equipment and facilities,
which are expensive to maintain and this cost con-
tributes toward the reduction in the availability of
PR at health care services [5-7].
The 6MWT is a widely accepted method for deter-
mining functional capacity for exercise, being com-
monly used in field studies due to its low-cost,
reproducibility, objectivity and easy application in
relation to patient age and education level [15,21].
It has also proven to be a predictor of post-pul-
monary rehabilitation survival [16,22]. According
to Weisman et al., the 6MWT has proven more sen-
sitive in detecting decline in SpO2 than a maximal
increment test on cycle ergometer for patients with
COPD [23].
In the present study, the variation in the distance
walked on the 6MWT following participation in the
PR program was statistically significant in both the
outpatient and at-home groups in comparison to the
control group (p < 0.05). The mean variation was
93.61 ± 70.57 meters in the outpatient group and
73.21 ± 50.21 meters in the at-home group.
According to Redelmeier et al., an increase in the
distance walked on the 6MWT of at least 54 meters
over baseline values is clinically important in terms
of the improvement in physical capacity [19]. This
has been confirmed in a number of studies assess-
ing PR programs [24,25]. 
The BODE index is considered a better predictor of
the risk of mortality due to both respiratory and
non-respiratory causes when compared to FEV1
alone [16]. In the present study, all groups demon-
strated a reduction in the BODE index. However,
the reduction was significantly greater in the outpa-
tient and at-home groups. The fact that an improve-
ment in the BODE index was found in all groups,
including the control group, is probably due to the
fact that all patients, regardless of the rehabilitation
modality, were rigorously treated with bronchodila-





















FIGURE 3: VARIATION ON SIX-MINUTE WALK TEST BETWEEN



















FIGURE 2: INTRA-GROUP RESULTS OF DISTANCE WALKED




















































tion of their pharmacological management during
the course of the study. 
For all the variables analyzed, the clinical benefits
achieved with PR performed in the clinical setting
were not significantly greater than those achieved
in the self-monitored home modality. This demon-
strates the efficacy of the home modality for the
management of patients with COPD, which allows
clinical benefits, lower costs and possibly greater
adherence due to the non-necessity of transporta-
tion to specialized clinics. Two previous studies
have assessed the effectiveness of self-monitored
home PR programs, but neither of them used a con-
trol group [27,28]. In a multicenter randomized
clinical trial, Maltais et al. found that both outpa-
tient and at-home PR interventions were equally
effective in promoting a clinical improvement in
dyspnea [26].
Another positive aspect of our study is that the drop-
out rate was notably less in the at-home group than
in the outpatient group (7 vs. 19). This difference is
likely due to the fact that carrying out a rehabilita-
tion program at home is logistically easier for
patients than travelling to a hospital clinic 3 times a
week. 
The present study had some limitations. The study
was carried out at a single center, more specifically
in a specialist pulmonology clinic, and subjects in
the different groups were not matched for age, BMI,
smoking status, FEV1, or baseline 6MWD.
Moreover, there was no evaluation of health-related
quality of life, which is another clinically important
outcome. 
CONCLUSION
The present study, despite the above limitations,
demonstrates that a self-monitored home pul-
monary rehabilitation program can achieve similar
results to a supervised outpatient pulmonary reha-
bilitation program and is a valid alternative in the
therapeutic approach to patients with COPD. The
data we provide show that self-monitored exercise,
truly home-based, following a short period of
instruction and education, can achieve equivalent
benefits in exercise capacity and body-index
scores. Considering the limited access to pul-
monary rehabilitation programs worldwide, offering
patients the opportunity of a home-based rehabili-
tation program can overcome the problems related
to outpatient rehabilitation (i.e. it is costly to pro-
vide and many patients have problems travelling to
the center several times per week). Hence, a broad-
scale use of the home program is recommended, as
this treatment modality is not limited by geographic
location and would enable a greater access of
patients with COPD to pulmonary rehabilitation. 
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